727650-61-5

Usage

Uses

Used in Pharmaceutical Industry:
6-Quinolinol, 3-amino(9CI) is used as an intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into drug molecules, potentially enhancing their efficacy and properties.
Used in Agrochemical Industry:
In the agrochemical industry, 6-Quinolinol, 3-amino(9CI) is used as a precursor for the development of pesticides and other agrochemicals. Its ability to form complexes with metal ions can contribute to the effectiveness of these products.
Used as a Chelating Agent:
6-Quinolinol, 3-amino(9CI) is used as a chelating agent in various applications. Its ability to bind with metal ions can be utilized in processes such as water treatment, where it can help remove heavy metals from water sources.
Used as a Corrosion Inhibitor:
6-Quinolinol, 3-amino(9CI) is also used as a corrosion inhibitor in industrial settings. Its complex-forming properties can help protect metal surfaces from corrosion, extending the lifespan of equipment and infrastructure.
Used in Antimicrobial and Antiviral Research:
6-Quinolinol, 3-amino(9CI) has been researched for its potential antimicrobial and antiviral properties. Its ability to interact with metal ions and form complexes may contribute to its effectiveness in inhibiting the growth of harmful microorganisms, making it a promising candidate for the development of new drugs in the medical and pharmaceutical fields.

Upstream product

• 7101-95-3 3-bromo-6-nitroquinoline 
• 7101-96-4 3-bromo-quinolin-6-ylamine 
• 29507-86-6 3-amino-6-methoxyquinoline 
• 159454-73-6 3-nitro-6-methoxyquinoline 
• 104-94-9 4-methoxy-aniline 
• 580-16-5 6-hydroxyquinoline 
• 1427474-53-0 N-benzyl-6-(benzyloxy)quinolin-3-amine 
• 1337882-50-4 6-(benzyloxy)-3-bromoquinoline 
• 13669-57-3 3-bromo-6-hydroxyquinoline 
• 1022151-47-8 3-bromoquinolin-6-yl acetate 
• 24306-33-0 methyl quinolin-6-ylethanoate 

Downstream Products

• 1451273-43-0 5-bromo-N-(6-hydroxyquinolin-3-yl)-2-methoxybenzenesulfonamide 
• 1451274-40-0 3-(5-bromo-2-methoxyphenylsulfonamido)quinolin-6-yltrifluoromethanesulfonate 
• 1451273-46-3 3-(5-bromo-2-methoxybenzenesulfonylamino)quinoline-6-carboxylic acid methyl ester 
• 1451273-47-4 3-(5-bromo-2-methoxybenzenesulfonylamino)quinoline-6-carboxylic acid 
• 1451273-48-5 3-(5-bromo-2-methoxybenzenesulfonylamino)quinoline-6-carboxylic acid amide 
• 1451273-49-6 3-(5-bromo-2-methoxybenzenesulfonylamino)quinoline-6-carboxylic acid methylamide 

Relevant academic research and scientific papers

2,2,3-Tribromopropanal as a versatile reagent in the skraup-type synthesis of 3-bromoquinolin-6-ols

2,2,3-Tribromopropanal, a reagent which almost became forgotten in the chemical literature after its first application in the 1950s, is used for the one-step transformation of diversely substituted 4-nitro- and 4-methoxyanilines into 3-bromo-6-nitroquinolines and 3-bromo-6-methoxyquinolines. These intermediates are then converted, in one further step, into 3-bromoquinolin-6- ols, which may carry additional substituents at positions 7 and 8. Georg Thieme Verlag Stuttgart New York.

SULFONAMIDE COMPOUNDS AND USES AS TNAP INHIBITORS

Described herein are compounds that modulate the activity of TNAP. In some embodiments, the compounds described herein inhibit TNAP. In certain embodiments, the compounds described herein are useful in the treatment of conditions associated with hyper- mineralization.

6 - SUBSTITUTED 3 - (QUINOLIN- 6 - YLTHIO) - [1,2,4] TRIAZOLO [4, 3 -A] PYRADINES AS TYROSINE KINASE

The invention relates to compounds of formula (I) and salts thereof: Formula (I) wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

TRIAZOLOPYRIDINE COMPOUNDS

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound o f formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I)